Description
Cardiseiv (Acetylsalicylic Acid) Coated Tablets 75 mg. №100
Composition
Each Cardiseiv coated tablet contains 75 mg of acetylsalicylic acid. Other ingredients include microcrystalline cellulose, maize starch, and colloidal anhydrous silica.
Mechanism of Action
Acetylsalicylic acid inhibits the enzyme cyclooxygenase, thereby reducing the production of prostaglandins which are involved in inflammation, pain, and fever.
Pharmacological Properties
Cardiseiv exhibits antiplatelet, analgesic, anti-inflammatory, and antipyretic properties due to its inhibition of prostaglandin synthesis.
Indications for Use
Cardiseiv is indicated for the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following bypass surgery.
Contraindications
- Hypersensitivity: Patients with hypersensitivity to acetylsalicylic acid or any of the excipients should not use Cardiseiv.
- Active Peptic Ulceration: Cardiseiv is contraindicated in patients with active peptic ulceration or any other bleeding disorders.
- Severe Hepatic Impairment: Patients with severe hepatic impairment should not use Cardiseiv.
Side Effects
Common side effects of Cardiseiv may include gastrointestinal disturbances, such as dyspepsia and gastritis, as well as an increased risk of bleeding due to its antiplatelet effects.
Usage Instructions
The usual dosage of Cardiseiv is one tablet daily. The tablet should be swallowed whole with a glass of water.
Benefits Compared to Analogues
Cardiseiv offers the advantage of secondary prevention of thrombotic events with a lower risk of gastrointestinal side effects compared to other antiplatelet medications.
Suitable Patient Groups
Cardiseiv is suitable for adults, including the elderly population, for the prevention of thrombotic events.
Storage and Shelf Life
Store Cardiseiv in a cool, dry place away from direct sunlight. Check the packaging for the expiry date. Do not use Cardiseiv after the expiration date.
Packaging Description
Cardiseiv is available in packs of 100 coated tablets.
